Analysts Expect Innophos Holdings, Inc. (IPHS) to Post $0.56 EPS

Innophos Holdings, Inc. (NASDAQ:IPHS) has been given an average broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy recommendation. Innophos’ rating score has improved by 50% from 90 days ago as a result of various analysts’ upgrades and downgrades.

Zacks has also assigned Innophos an industry rank of 100 out of 265 based on the ratings given to related companies.

IPHS has been the subject of a number of research reports. Zacks Investment Research cut shares of Innophos from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. KeyCorp reaffirmed a “hold” rating on shares of Innophos in a research note on Wednesday, November 1st. Finally, BidaskClub raised shares of Innophos from a “sell” rating to a “hold” rating in a research note on Thursday, December 14th.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. grew its stake in Innophos by 1.4% during the 4th quarter. BlackRock Inc. now owns 2,492,051 shares of the specialty chemicals company’s stock valued at $116,453,000 after acquiring an additional 34,169 shares in the last quarter. Vanguard Group Inc. grew its stake in shares of Innophos by 2.9% in the 2nd quarter. Vanguard Group Inc. now owns 1,926,577 shares of the specialty chemicals company’s stock valued at $84,460,000 after buying an additional 54,505 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Innophos by 1.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 988,323 shares of the specialty chemicals company’s stock valued at $48,616,000 after buying an additional 14,862 shares during the period. Frontier Capital Management Co. LLC grew its stake in shares of Innophos by 1.5% in the 3rd quarter. Frontier Capital Management Co. LLC now owns 869,238 shares of the specialty chemicals company’s stock valued at $42,758,000 after buying an additional 12,808 shares during the period. Finally, Segall Bryant & Hamill LLC grew its stake in shares of Innophos by 11.0% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 820,518 shares of the specialty chemicals company’s stock valued at $40,361,000 after buying an additional 81,550 shares during the period. 95.07% of the stock is owned by institutional investors.

Shares of Innophos (IPHS) opened at $42.28 on Tuesday. The company has a market cap of $814.75, a PE ratio of 19.48 and a beta of 0.76. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.49 and a current ratio of 2.86. Innophos has a one year low of $40.45 and a one year high of $58.22.

TRADEMARK VIOLATION NOTICE: “Analysts Expect Innophos Holdings, Inc. (IPHS) to Post $0.56 EPS” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2018/02/13/analysts-expect-innophos-holdings-inc-iphs-to-post-0-56-eps.html.

Innophos Company Profile

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply